slidedeck.co

Sharper Sense pitch deck, 2020

Cover slide of the Sharper Sense 2020 pitch deck
Cover of Sharper Sense's 2020 pitch deck.

The deck opens with the company name and a title slide, then states the problem: impaired sensory processing from aging, neurological disorders, fatigue and injury reduces acuity and raises fall risk. It presents a noninvasive vagus nerve stimulation patch as the solution. Next it explains the mechanism through a brain-pathway diagram, lists the drawbacks of alternatives such as stimulants, nootropics and therapy, and cites the academic papers behind the approach. The product section covers form factor, features and target price, followed by a competitor comparison table of VNS devices by application, form factor and stimulation location. The deck then describes the consumer impact of age-related sensory decline and sizes adjacent markets. A revenue and gross margin projection table from 2024 to 2029 is followed by a regulatory and reimbursement plan, expansion markets, a timeline of research, funding and milestones, a proposed pilot study, the founding team and partner institutions. It closes with a seed round ask of $400K and contact details.

Slides worth studying

Slide 3 of the Sharper Sense pitch deck, reads "Periphery Thalamus Cortex Perception Sharper Sense enhances Sensory Processing Perceptual acuity depends on accurate sensory processing Aging, fatigue, injury,". Flow diagram: three rows of rounded-corner thumbnails on left, each with a black arrow pointing right: row 1 Mona Lisa painting (to) green-brown human eye photo; row 2 black desktop speaker (to) human ear photo; row 3 ke
Slide 3: A simple two-panel diagram links periphery, thalamus and cortex to show the mechanism in one glance.
Slide 7 of the Sharper Sense pitch deck, reads "Our stimulation pattern differentiates Sharper Sense from existing VNS devices Application VNS Pattern Form Factor VNS Location Sharper Sense Sensory processing". Table with 5 columns (row label, Application, VNS Pattern, Form Factor, VNS Location) and 9 rows, with the header row in bold black sans-serif. Row labels are bold black, except the parenthetical former names, which are
Slide 7: The competitor table organizes rivals by application, pattern, form factor and stimulation site, making the positioning easy to compare.
Slide 12 of the Sharper Sense pitch deck, reads "Translating technology from academia to industry Research and Development Funding Jan 2021 Preclinical Proof of Concept in Awake Rats Translational Research (J". Timeline diagram. A pale blue-grey arrow with circular dot markers at each year. Above the arrow, navy rectangular bars with white text: Translational Research (J Neural Engr, 2020); Business Dev. & Acceleration (BiomedX
Slide 12: A single timeline combines research, grants, funding rounds and regulatory steps, showing the path from academic work to market.

Questions about this deck

What revenue and gross margin does the Sharper Sense deck project for 2024 to 2029?

Slide 10 projects revenue of $0.9M in 2024, rising to $287M in 2029, with gross margin of 13% in 2024 and 77% in 2028 and 2029. The projections cover age-degraded sensory processing only, and other applications are not included.

What is the Sharper Sense target price and expected cost per patch in its deck?

Slide 6 states that the target price is $15 per patch. It also states that expected COGS at volume is less than $5 per patch.

How many slides does the Sharper Sense presentation deck have, and how is it structured?

The Sharper Sense deck has 16 slides. It opens with the title slide on slide 1, states the problem on slide 2, presents the solution and mechanism on slides 3 to 6, and closes with the seed round ask and contact details on slide 16.

How much seed funding is Sharper Sense raising according to its deck?

Slide 16 says Sharper Sense is actively raising a seed round of $400K. It also states that $50K of this round had been raised as of Jan. 2021.

Details

  • Company: Sharper Sense
  • Year: 2020
  • Type: Pitch deck
  • Industry: Neurotechnology
  • Pages: 16

Review score: 6 out of 10, Needs substantial work

Presentation quality, judged with the SlideDeck Co review heuristic. Ask, evidence and idea merit are not rated here.

The deck has a clear story from problem to mechanism to product, competitors, market, plan, team and ask, and several slides are well built: the competitor table on slide 7 is easy to read and the pitch is rendered consistently in blue with a repeated footer. But slide 2 puts the problem and solution in small dense text beside four crowded photos, and slide 3 mixes a pathway diagram with a cartoon whose purpose is unclear. The timeline on slide 12 and the pie chart on slide 16 are crowded, with tiny labels and overlapping markers, and slides 10, 11 and 13 rely on small text that would be hard to read in a room. The core case is recoverable, but a presenter would need to tidy many slides and fix the hierarchy before the deck is easy to follow.

Worth keeping: Keep the green and red comparison table on slide 7, the headline-as-claim titles in blue, the consistent footer and logo, and the sequence from problem through mechanism to ask.

Most useful repair: Simplify slide 2 into a single headline with one image, enlarge and declutter the timeline on slide 12, and replace the pie on slide 16 with a sorted bar chart or a grouped list with larger labels.

What would change the score: I would remove the cartoon on slide 3, split slide 11 into fewer groups with bigger text, and drop the small caption text on slide 5 or move it to a footnote.

Confidence medium. 16 of 16 pages inspected on contact sheets, 4 at readable size. Reviewed 2026-11-08. Model-assisted review (claude-sonnet-5-5).

Full text of the slides (16 slides)

Every slide's words and a description of its charts and images, so the deck can be searched and rebuilt. Also available as Markdown.

Slide 1

Sharper Sense

Instant sensory processing enhancement

www.SharperSense.com

Charles Rodenkirch, PhD

[email protected]

(646) 470-3040

© 2020 Sharper Sense

All rights reserved

Visuals: A thick horizontal blue rule (about #2F5597) spans from about 14% to 86% of slide width beneath the title. In the bottom-left corner is the Sharper Sense logo: a tall condensed black stylised wordmark with a large 'S' and the words 'harper' on the top line and 'ense' on the bottom line, on a white rounded-square background.

Slide 2

Enhance

your senses

Tactile

Auditory

Visual

The Problem:

• The brain’s ability to accurately process sensory information received from the eyes, ears, and skin

can be impaired by aging, numerous neurological disorders, fatigue, inattention, and brain injury

• Impaired sensory processing reduces sensory acuity, makes it difficult to understand written and

spoken words, increases risk of fall and injury, and decreases performance at work, school, or play

Our Solution:

• A noninvasive nerve stimulation patch that restores sensory processing clarity via neuromodulation

© 2020 Sharper Sense

All rights reserved

Visuals: Sharper Sense logo: black stacked wordmark 'Sharper' over 'Sense' with a large S in a condensed font, on a white rounded-rectangle tile. Photo 'Auditory': elderly grey-haired woman with glasses holding a phone to her ear, other hand under her chin, with a worried expression, bright white background, grey sweater. Photo 'Tactile': close-up of hands peeling a red apple with a knife, warm tones. Photo 'Visual': man with dark hair and glasses reading a large newspaper, green plant at right, grey tones. Large photo: side profile of a middle-aged woman with long dark brown hair, hand under her chin, a small triangular translucent patch with the Sharper Sense logo on her neck/jaw, white background, grey top at bottom right. All photos have rounded corners. Small Sharper Sense logo at bottom left on a white rounded tile. Each of the three small photos has a small light-grey label strip at its bottom holding bold black text.

Slide 3

Sharper Sense enhances

Sensory Processing

Periphery

Thalamus

Cortex

Perception

Perceptual acuity depends on accurate sensory processing

Aging, fatigue, injury, and neurodisorders

can greatly impair sensory processing

Suboptimal sensory processing

introduces noise that degrades acuity

© 2020 Sharper Sense

All rights reserved

knees

cheese

fleas?

Visuals: Three rows of rounded, shadowed thumbnails. Row 1: Mona Lisa painting, black arrow, close-up of a green-hazel human eye. Row 2: grey desktop speaker, black arrow, close-up of a human ear. Row 3: braille-marked metal keypad button '5 JKL', black arrow, a hand with outstretched fingers. A large black right brace joins the three rows, with an arrow pointing to a rounded image of glowing blue neurons. A black arrow leads to Thalamus, then arrow to Cortex, then arrow to Perception (underlined). A black curly bracket sits above Thalamus and Cortex and points up to the text 'Sharper Sense enhances Sensory Processing', flanked by two yellow lightning bolts. At lower right is a rounded, shadowed illustration of three children with speech bubbles reading 'knees', 'cheese', 'fleas?' on a beige background. The Sharper Sense logo sits at bottom left, a stylised black 'S' with 'harper' and 'ense' in condensed letters.

Slide 4

Existing methods of improving sensory processing are less than ideal

Stimulants are not safe and cause insomnia, / anxiety, loss of appetite, and cardiac damage

Externally processing audio/video / unnaturally distorts sensory stimuli

Therapy promoting neuroplasticity requires / extensive time and money before any benefit

Nootropics are not effective / and rarely tested for safety

© 2020 Sharper Sense

All rights reserved

Visuals: Four rounded-corner photos with soft drop shadows and a glossy edge: (1) top-left, close-up of a white Ritalin 10 mg methylphenidate tablet bottle with label text, blue edge at right; (2) mid-right, side view of a woman with blonde hair wearing a grey VR headset, green tropical leaves behind; (3) left, a child with headphones in a sensory gym stepping on dome balance pods over colourful floor mats, with a blue bolster and blue crash mat, yellow and pink walls; (4) bottom-right, a hand holding a dark blue Zhou NEURO-PEAK supplement bottle with a mountain logo. Bottom-left Sharper Sense logo: stylised black letters 'Sharper Sense' with a large S, on a white rounded tile.

Slide 5

The brain naturally optimizes sensory processing when alert/attentive

Decreased / Detail

Attention/Arousal

Low

High

Increased / Detail

Vagus nerve stimulation

LC-NE activation

Enhanced sensory / processing & acuity

Enhanced performance

Our team Identified neural circuitry responsible for arousal-linked enhanced sensory processing

We confirmed direct activation of this circuitry in awake rats enhances perceptual acuity

We then optimized a peripheral nerve stimulation method of indirectly activating this circuitry

Charles Rodenkirch, Yang Liu, Brian J Schriver, and Qi Wang. Locus coeruleus activation enhances thalamic feature selectivity via norepinephrine regulation of intrathalamic circuit dynamics. Nature Neuroscience, 2019.

Charles Rodenkirch and Qi Wang. Rapid and transient enhancement of thalamic information transmission induced by vagus nerve stimulation. Journal of Neural Engineering, 2020.

nature neuroscience

JOURNAL OF NEURAL ENGINEERING

© 2020 Sharper Sense

All rights reserved

Visuals: Two rounded-square images of the Mona Lisa with drop shadows: left one heavily blurred (low detail), right one sharp (high detail); each has white overlay text at its lower middle. A thick black double-headed horizontal arrow sits between them, with the label Attention/Arousal above and Low and High below its ends. Three small black down arrows link the right-hand text steps. Logos: the Nature Neuroscience logo (white text on dark teal rounded rectangle), the Journal of Neural Engineering logo (blue and red text on pale background), and the Sharper Sense logo (black stylised S with 'harper' and 'ense').

Slide 6

Our technology: a noninvasive neuromodulation patch that / improves sensory acuity by enhancing sensory processing

Externally worn vagus nerve stimulation (VNS) patch

Easy to take on and off

Proprietary VNS pattern enhances sensory processing

Enhancement occurs within seconds of activation

No unnatural distortion of vision, hearing, or touch

Less than 3 mm thick with 6-8 hours of battery life

Doesn’t obstruct eyes or ears

Transcutaneous stimulation is noninvasive and pain-free

Target price is $15 per patch

Expected COGS at volume is less than $5 per patch

© 2020 Sharper Sense

All rights reserved

Visuals: Photograph of a middle-aged woman with grey-streaked dark hair in profile facing left, her hand resting under her chin. A small triangular silver patch labelled 'Sharper Sense' is on her neck below the jaw. Soft light, pale grey-white background, grey-blue top at the bottom. The photo is boxed with rounded corners and a soft drop shadow. Bottom-left corner: Sharper Sense logo with a large black stylised 'S' and the words 'harper' and 'ense' in condensed black letters, on a white rounded box.

Slide 7

Our stimulation pattern differentiates Sharper Sense from existing VNS devices

Application

VNS Pattern

Form Factor

VNS Location

Sharper Sense

Sensory processing

Continuous

Wearable

Neck

LivaNova (formerly Cyberonics)

Epilepsy, depression, hypertension

Cycled on/off

Implanted

Neck

Setpoint

Autoimmune

Brief session

Implanted

Neck

Microtransponder

Stroke, tinnitus

Brief session

Implanted

Neck

Electrocore

Migraine

Brief session

Handheld

Neck

Innovative Health Solutions

Pain, opioid withdrawal

Cycled on/off

Wearable

Ear

tVNS Tech (formerly Cerbomed)

Epilepsy

Cycled on/off

Handheld

Ear

Spark Biomedical

Opioid withdrawal

Brief session

Handheld

Ear

Parasym

Depression, tinnitus

Brief session

Handheld

Ear

© 2020 Sharper Sense

All rights reserved

Visuals: Comparison table with a white header row with bold black column headings (the first header cell is empty). Row labels are on white. Data cells are colour-coded: green for the Sharper Sense row and for matching attributes, pink for differing ones, with thin white gaps between cells. Row 1 Sharper Sense: all four cells green. Rows LivaNova, Setpoint, Microtransponder: Application and VNS Pattern pink, Form Factor (Implanted) pink, VNS Location (Neck) green. Electrocore: Application, Pattern, Form Factor (Handheld) pink, Location (Neck) green. Innovative Health Solutions: Application and Pattern pink, Form Factor (Wearable) green, Location (Ear) pink. tVNS Tech, Spark Biomedical and Parasym: all four cells pink. Bottom-left logo: the Sharper Sense wordmark in black condensed lettering, with a large 'S' on 'harper' and 'ense' below it.

Slide 8

Sharper Sense’s technology has many potential applications

First target market: age-related sensory processing deficits

Age-degraded sensory processing is isolating and dangerous

Affects the vast majority of seniors

Interferes with communication

Increases likelihood of falls

Accelerates dementia onset and progression

Precludes employment and recreation

Leads to depression and anxiety

© 2020 Sharper Sense

All rights reserved

Visuals: Photograph of an older woman with light grey-blonde hair, seen in close-up, squeezing her eyes shut in discomfort. One hand rubs her eyes and the other holds red-burgundy framed glasses against her forehead. Soft, neutral, warm indoor lighting with a blurred light background and beige clothing. Boxed with large rounded corners and a soft feathered edge/shadow. Bottom-left corner has the Sharper Sense logo: a stylised black serif-condensed 'Sharper Sense' wordmark with a large S and D-like shape, stacked on two lines on a white rounded tile. Underlined words in the bullets: falls, dementia, depression, anxiety.

Slide 9

Restoring high-fidelity sensory processing in seniors

is at the intersection of multiple growing markets

Market size (global)

CAGR

Neuromodulation:

$6B

9%

Human augmentation:

$71B

24%

Elderly and disabled assistive devices:

$23B

6%

Hearing aids:

$9B

7%

Vision care :

$52B

4%

[Data from Allied Market Research, Imarc, and MarketsandMarkets]

© 2020 Sharper Sense

All rights reserved

Visuals: Table with an empty top-left header cell, header cells 'Market size (global)' and 'CAGR', and five rows: Neuromodulation: $6B, 9%; Human augmentation: $71B, 24%; Elderly and disabled assistive devices: $23B, 6%; Hearing aids: $9B, 7%; Vision care : $52B, 4%. Row labels sit in pale blue cells, right-aligned. Value cells are light grey and centred. Thin white gaps separate the cells. Top photo: close-up of an elderly white-haired man with glasses cupping his hand behind his ear, bright high-key lighting, blue collar and navy cardigan, white background, rounded corners with a soft shadow. Bottom photo: an elderly grey-haired woman in a blue sweater sitting on a sofa, looking down through a magnifying glass at an open book, soft daylight, blue and green tones, rounded corners with a soft shadow. Bottom-left logo: 'Sharper Sense' in black condensed stylised lettering with a large S and a large S dropping below.

Slide 10

We will leverage our solid science to gain de novo clearance as

a prescription treatment for age-degraded sensory processing

Using our networks and future marketing team we will drive adoption by prescribing physicians

2024

2025

2026

2027

2028

2029

Revenue:

$0.9M

$2.5M

$24M

$55M

$134M

$287M

Gross Profit:

$0.1M

$1M

$13M

$37M

$103M

$220M

Gross Margin:

13%

40%

53%

67%

77%

77%

[Revenue projections from age-degraded sensory processing only, other applications not included]

Aggressively pursuing eligibility for reimbursement by 3rd party payers is key to our success,

we expect a favorable likelihood of approval due to our strong value versus existing treatments

© 2020 Sharper Sense

All rights reserved

Visuals: Photograph of a doctor's hands (white coat sleeve visible) writing a prescription with a silver pen on a light blue pad printed with an Rx symbol; close-up, soft focus background in teal-green and warm skin tones, boxed in a rounded-corner rectangle with a soft vignette edge. Table: header row of years 2024-2029 on pale blue cells; row labels Revenue:, Gross Profit:, Gross Margin: on pale blue cells, right-aligned; data cells light grey. Revenue $0.9M, $2.5M, $24M, $55M, $134M, $287M; Gross Profit $0.1M, $1M, $13M, $37M, $103M, $220M; Gross Margin 13%, 40%, 53%, 67%, 77%, 77%. Small white gaps separate the cells. Bottom-left logo: stylised 'Sharper Sense' wordmark in black with a large S and a large D-like S on a second line.

Slide 11

Abundant potential for future expansion into multiple markets

Clinical Applications

(Class 2 nonsignificant risk medical device)

Performance Enhancement Applications

(General wellness device)

Sensory Processing

Degradation

Age-related, Parkinson’s,

Multiple sclerosis

Sensory Processing

Disorders

ADHD, Autism, Dyslexia,

Language impairment,

Audiovisual disorders

Demanding &

Hazardous Jobs

Sports & E-Sports

Those suffering from impaired sensory processing are in dire need of a safe and effective way to restore sensory clarity

Sharper Sense has spoken to multiple military groups interested in testing our technology as soon as it is available

We have received similar interest from athletes and e-athletes we’ve spoken with

© 2020 Sharper Sense

All rights reserved

Visuals: Two red-outlined rounded cards each contain the same colourful translucent brain illustration (multicoloured wireframe brain, green, blue, orange, magenta, in a white rounded square with soft shadow). The blue card 'Demanding & Hazardous Jobs' has two overlapping rounded-corner photos: a camouflaged soldier in a boonie hat aiming a scoped sniper rifle against a cloudy sky (upper left), and a female worker in a yellow hard hat, safety glasses and plaid shirt working on machinery (lower right). The blue card 'Sports & E-Sports' has two overlapping photos: a golfer in a purple shirt and grey trousers putting on a green with a flag (upper left), and hands holding a black Xbox-style game controller (lower right). Sharper Sense logo at bottom left: stylised black 'Sharper Sense' wordmark with large S letters.

Slide 12

Translating technology from academia to industry

Research and

Development

Jan 2021

Optional Product to Market

(Consumer Application, General Wellness Device)

Preclinical Proof of

Concept in Awake Rats

1st Clinical Proof

of Concept

1st Gen. Hardware

Produced

Submit De Novo to FDA

(Class 2 Nonsignificant Risk Device)

Translational Research

(J Neural Engr, 2020)

Business Dev. & Acceleration

(BiomedX, ELabNYC)

Device Design

& Production

External Clinical

Trials

Product to Market

(Clinical Application, Medical Device)

Academic Research

(Nature Neuro, 2019)

Fully Elucidated

Mechanism of Action

Internal Pilot Clinical Studies – 1. Healthy Adults 2. Age-degraded

Sensory Processing 3. ADHD 4. Dyslexia + five additional targets

2018

2020

2022

2024

2019

2021

2023

2025

Research Funded by Academic Grants (NIH R01 $2M, NSF CAREER $0.5M)

NIH NIA SBIR Phase

I Grant ($250K)

NIH NIA SBIR Phase II Grant

($1.6M)

EXIT

Company

Incorporated

NIH I-Corps

Grant ($60K)

Funding

Seed Funding

($400K)

Series A

($2M)

Series B

We are actively raising $400K in seed funding to conduct pilot clinical studies

© 2020 Sharper Sense

All rights reserved

Visuals: Timeline arrow (light lavender, right-pointing) with seven blue circular markers at 2018 through 2025 positions. A vertical red line at Jan 2021 and a light grey rectangular band from about 2021 to mid 2022 behind the content. Navy rectangles with white text for R&D phases. Medium green rectangles for grants. Dark green rectangles for equity funding rounds. Red five-point stars mark milestones: Fully Elucidated Mechanism of Action, Preclinical Proof of Concept, 1st Clinical Proof of Concept, 1st Gen. Hardware Produced, Optional Product to Market, Product to Market, EXIT. A small navy square marks the Submit De Novo to FDA entry and a black square marks Company Incorporated. Sharper Sense logo at bottom left, a stylised black handwritten 'Sharper Sense' wordmark with large S letters.

Slide 13

Our proposed pilot clinical study plan will validate our technology’s

beneficial effect in humans as well as prove its clinical value

Sensory stimuli:

Visual (LCD screen)

Auditory (headphones)

Tactile (haptic feedback)

Transcutaneous nerve stimulation:

Vagus nerve

Sham location

Experimental subject:

Seated at computer

Measure sensory performance:

With and without nVNS

Measure physiology:

Pupil dilation (index of target circuitry activation)

Galvanic skin response

Heart rate variability

nVNS will be delivered with a programmable, desktop size, medical stimulator FDA cleared for human use

Vision: Gratings

Tactile: Vibration

Auditory: Tone

1. Tactile, auditory, and visual frequency discrimination testing in healthy adults

Snellen Chart

QuickSIN

2. Standardized visual acuity and speech intelligibility testing in seniors with impaired audiovisual ability

IVA-AE2

3. Continuous performance tests (CPT, audiovisual discrimination) in adults with ADHD

TAPS-3

CTOPP-2

4. Visual (reading) and auditory (speech) processing tests in adults with dyslexia

5. Subsequently test five additional clinical targets

© 2020 Sharper Sense

All rights reserved

Visuals: Grey cartoon illustration of a seated man with glasses typing at a computer monitor and keyboard, centered. Four dark grey block arrows: two pointing right from the left lists to the subject, two from the subject to the right lists. Thick grey horizontal rule separates the grey panel from the lower section, with three grey vertical dividers. Lower panels: two circular vertical grating patterns in grey stripes; a hand pressing a fingertip with vibration motion lines; two music staves with treble clef and musical notes; a Snellen eye chart on a black computer monitor; a QuickSIN yellow-red-orange DVD case with disc; a diagram of three stacked grey rectangles stepping up diagonally labeled with +, 1, + and red (1) (2) markers, a speaker icon with “Five” in the top box and a thin black arrow pointing up-right; a TAPS-3 orange-brown box with CD and booklet; a CTOPP-2 blue and orange box with stopwatch image. Sharper Sense logo in black stylised lettering at bottom left.

Slide 14

Our / Founding / Team

Charles Rodenkirch, PhD

President of Sharper Sense (full-time)

Biomedical engineer, systems neuroscientist

Worked for Columbia Technology Ventures

Second-time entrepreneur

Professor Qi Wang, PhD

Consultant to Sharper Sense (part-time)

Columbia Professor of Biomedical Engineering

Head of Neural Engineering Lab

Doctorates in electrical engineering & robotics

Scientific Advisory Board

Professor Jason Carmel, MD, PhD

Columbia Professor of Pediatric Neurology and practicing neurologist

Expert in clinical neural stimulation & sensorimotor neurology

Business Advisory Board

John Sullivan, MBA

Leader in healthcare innovation with extensive business development experience

BioHealth Innovation Entrepreneur In Residence

© 2020 Sharper Sense

All rights reserved

Visuals: Five photos with rounded corners and soft drop shadows: (1) wide group photo in a lab at top, two smiling men standing side by side, the left a young man in a white lab coat over a maroon shirt, the right a man in a tan checked blazer and blue shirt, with a white microscope/robotic arm setup with orange knobs and lab equipment racks and glass cabinets behind; (2) headshot of Charles Rodenkirch, young man with short brown hair in dark suit and white shirt against a brick wall; (3) headshot of Professor Qi Wang, man with glasses in dark suit, light blue shirt and blue tie against a pale blue background; (4) headshot of Jason Carmel, smiling man with dark hair in a white coat over a blue checked shirt; (5) headshot of John Sullivan, grey-haired man with glasses in a dark suit, light blue shirt and red patterned tie. Small square bullets in dark grey. Sharper Sense logo at bottom left: stylized black 'S' with 'harper' and 'ense' lettering. A vertical grey divider line between the halves.

Slide 15

Supporting preclinical research was conducted at:

COLUMBIA | ENGINEERING

The Fu Foundation School of Engineering and Applied Science

Biomedical Engineering

Laboratory for Neural Engineering and Control

Intellectual property protected by:

PCT patent application filed 6/2020, additional provisional patent application filed 9/2020

IP covers novel VNS application, proprietary VNS pattern, device aspects, and accurate application methods

Sharper Sense is in the process of converting our exclusive option agreement to an exclusive license

COLUMBIA | TECHNOLOGY VENTURES

Honored to have been accepted and participated in:

ENTREPRENEURSHIP LAB

BIO AND HEALTH TECH NYC

COLUMBIA | BIOMEDX

Biomedical Technology Accelerator

Legal counsel:

WILSON SONSINI

Sharper Sense

© 2020 Sharper Sense

All rights reserved

Visuals: Logos: Columbia Engineering Biomedical Engineering / Laboratory for Neural Engineering and Control, on a white rounded card with a soft shadow, navy crown emblem and navy serif text. Columbia Technology Ventures: a blue glossy rounded banner with a white crown and white small-caps serif text. Entrepreneurship Lab Bio and Health Tech NYC: white rounded card with a teal, green and blue ring at left and grey condensed text. Columbia BioMedX Biomedical Technology Accelerator: white rounded card with navy crown and serif text. Wilson Sonsini: dark teal rounded square with white spaced capitals and a red-pink stripe at the bottom. Sharper Sense logo: black stylised lettering at bottom-left on a white tile.

Slide 16

We are actively raising a seed round of $400K

$50K of this round has been raised as of Jan. 2021

This funding will be efficiently spent to generate clinical proof of concept for multiple applications, protect our IP, and validate our hardware development plan

At our current lean burn rate, the requested funding could conduct 18 months of pilot clinical studies

We expect to produce our first clinical proof of concept within 6-9 months, at which point we can slowly accelerate burn to build our team for a series A raise

Contact: Charles Rodenkirch, PhD

[email protected]

(646) 470-3040

Anticipated Distribution of Funding Use

Personnel 22%

Taxes 1%

Legal 9%

Insurance 4%

Facilities 11%

Misc 5%

Patents 27%

Consumables 2%

Equipment 6%

Subjects 11%

Design 2%

© 2020 Sharper Sense

All rights reserved

Visuals: Pie chart titled 'Anticipated Distribution of Funding Use', 11 slices with white separators, each labelled with category and percentage in white bold text on dark semi-transparent grey label boxes with a slight shadow. Clockwise from top (about 12 o'clock): Personnel 22% (medium blue #4472C4), Taxes 1% (orange #ED7D31), Legal 9% (purple #7F3880), Insurance 4% (yellow-gold #FFC000), Facilities 11% (light blue #5B9BD5), Misc 5% (green #70AD47), Patents 27% (dark navy #264478), Consumables 2% (rust brown #9E480E), Equipment 6% (dark grey #636363), Subjects 11% (olive brown #7F6000), Design 2% (grey #808080). No legend. A thin black-outlined rectangle surrounds the contact text. Bottom-left corner has the Sharper Sense logo: stylised black text 'Sharper Sense' with large S and S, in two lines, on white.

Download this deck

The hosted PDF of every library deck is free for readers of the SlideDeck Co newsletter. Join with your email and the viewer and download appear here.

Building a pitch deck of your own? The SlideDeck Co Startup Deck is a slide library with a worked investor pitch and financial model.

More Investor pitch decks

Deck reviews in your inbox.

See what works in real company decks, what we’d change, and get the latest SDC releases.

Expanded slide preview